Global stocks head for record high on vaccine hopes

LONDON/SYDNEY: Global stocks eyed a fresh record high on Monday as signs of economic recovery in China and Japan, recent strong corporate earnings and hopes of a COVID-19 vaccine bolstered investor sentiment.
The MSCI World Index of global shares rose 0.4% to 608.98 points, just shy of the record high hit briefly earlier in the month, helped by strong overnight gains in Asia’s leading markets and a stronger open for most European bourses.
MSCI’s broadest index of Asia-Pacific shares outside Japan .MIAPJ0000PUS hit its highest level since launching in 1987 as Japan pulled out of recession, China posted better-than-expected industrial output data and the region signed the largest ever trade deal.
Taking their lead, European indices also rose with Britain’s FTSE 100 .FTSE and the pan-Europe STOXX Europe 600 .STOXX both up around 0.7%.
U.S. stock futures ESc1 pointed to a similarly positive start for Wall Street trade later in the day.
“With the futures pencilling in a 300 point rise, the Dow is set to start the week at 29,770, finally making good on the all-time high intraday levels struck this time last week,” said Connor Campbell, financial analyst at Spreadex.
The prospect of economic recovery also helped oil prices strengthen, with both Brent crude futures LCOc1 and West Texas Intermediate up around 1%.
Amid all the optimism, European government bond yields also fell back with Italian benchmark 10-year yields down 3 basis points.
Not every asset was swept up by the rising tide, however, with the dollar down slightly against a basket of currencies =USD, weighed by fresh data over the weekend showing an increase in the number of COVID-19 cases.
Gold XAU= steadied near a one-week high, up 0.2% to $1,892 an ounce. While rising cases of the coronavirus were a risk, Morgan Stanley strategists urged investors to “keep the faith” in their 2021 outlook note. – PNP